Literature DB >> 17136330

Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model.

David J Brooks1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17136330     DOI： 10.1007/s00508-006-0737-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  16 in total

1.  Evidence for striatal dopamine release during a video game.

Authors:  M J Koepp; R N Gunn; A D Lawrence; V J Cunningham; A Dagher; T Jones; D J Brooks; C J Bench; P M Grasby
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

2.  Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.

Authors:  H T Benamer; J Patterson; D J Wyper; D M Hadley; G J Macphee; D G Grosset
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

3.  Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

Authors:  F J Vingerhoets; M Schulzer; D B Calne; B J Snow
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

4.  Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

Authors:  Christine Brefel-Courbon; Pierre Payoux; Claire Thalamas; Fabienne Ory; Isabelle Quelven; François Chollet; Jean Louis Montastruc; Olivier Rascol
Journal:  Mov Disord       Date:  2005-12       Impact factor: 10.338

5.  Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study.

Authors:  Ines K Goerendt; Cristina Messa; Andrew D Lawrence; Paul M Grasby; Paola Piccini; David J Brooks
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

Review 6.  Dopamine dysregulation syndrome in Parkinson's disease.

Authors:  Andrew H Evans; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

7.  Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

Authors:  E D Playford; I H Jenkins; R E Passingham; J Nutt; R S Frackowiak; D J Brooks
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

8.  Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.

Authors:  O Rascol; U Sabatini; F Chollet; P Celsis; J L Montastruc; J P Marc-Vergnes; A Rascol
Journal:  Arch Neurol       Date:  1992-02

9.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

Authors:  Philippe Remy; Miroslava Doder; Andrew Lees; Nora Turjanski; David Brooks
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

10.  Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.

Authors:  A L Cheesman; R A Barker; S J G Lewis; T W Robbins; A M Owen; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.